Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors

Kidney International

Volumn 82, Issue 7, 2012, Pages 812-818

  Conway, Bryan R ^a   Manoharan, Deepika ^b   Manoharan, Divya ^b   Jenks, Sara ^c   Dear, James W ^a   McLachlan, Stela ^d   Strachan, Mark W J ^e   Price, Jackie F ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

diabetic nephropathy; microalbuminuria; mortality risk; progression of renal failure; tubular epithelium

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; GLUCOSE; GLYCOPROTEIN NON METASTATIC MELANOMA B; HEMOGLOBIN A1C; KIDNEY INJURY MOLECULE 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

EID: 84866372250     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.218     Document Type: Article

References (22)

1. US Renal Data System USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2009.
2. Nathan DM, Zinman B, Cleary PA et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Int Med 2009; 169: 1307-1316.
3. de Boer IH, Sun W, Cleary PA et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011; 365: 2366-2376.
4. Karalliedde J, Viberti G. Proteinuria in diabetes: bystander or pathway to cardiorenal disease? J Am Soc Nephrol 2010; 21: 2020-2027.
5. Perkins BA, Ficociello LH, Silva KH et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003; 348: 2285-2293.
6. Nielsen SE, Andersen S, Zdunek D et al. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 2011; 79: 1113-1118.
7. Nielsen SE, Sugaya T, Hovind P et al. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 2010; 33: 1320-1324.
8. von Eynatten M, Baumann M, Heemann U et al. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes. Eur J Clin Invest 2010; 40: 95-102.
9. Vaidya VS, Niewczas MA, Ficociello LH et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetylbeta-D- glucosaminidase. Kidney Int 2011; 79: 464-470.
10. Nielsen SE, Hansen HP, Jensen BR et al. Urinary neutrophil gelatinaseassociated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study. Nephron Clin Practice 2011; 118: c130-c135.
11. Krams SM, Fox CK, Beatty PR et al. Human hepatocytes produce an isoform of FAS that inhibits apoptosis. Transplantation 1998; 65: 713-721.
12. Conway BR, Rennie J, Bailey MA et al. Hyperglycemia and Renin-Dependent Hypertension Synergize to Model Diabetic Nephropathy. J Am Soc Nephrol 2011.
13. Patel-Chamberlin M, Wang Y, Satirapoj B et al. Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species. Kidney Int 2011; 79: 1138-1148.
14. Li B, Castano AP, Hudson TE et al. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. Faseb J 2010; 24: 4767-4781.
15. Tang SC, Leung JC, Lai KN. Diabetic tubulopathy: an emerging entity. Contr Nephrol 2011; 170: 124-134.
16. Kramer HJ, Nguyen QD, Curhan G et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273-3277.
17. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007; 71: 967-970.
18. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
19. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Int Med 2009; 150: 604-612.
20. Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 2012; 23: 13-21.
21. Price JF, Reynolds RM, Mitchell RJ et al. The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endo Disord 2008; 8: 18.
22. Marioni RE, Strachan MW, Reynolds RM et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010; 59: 710-713.